Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease

Saifun Nahar, Yoshiki Nakashima, Chika Miyagi-Shiohira, Takao Kinjo, Zensei Toyoda, Naoya Kobayashi, Issei Saitoh, Masami Watanabe, Hirofumi Noguchi, Jiro Fujita

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Adipose-derived mesenchymal stem cells (ADSCs) are a treatment cell source for patients with chronic liver injury. ADSCs are characterized by being harvested from the patient's own subcutaneous adipose tissue, a high cell yield (i.e., reduced immune rejection response), accumulation at a disease nidus, suppression of excessive immune response, production of various growth factors and cytokines, angiogenic effects, antiapoptotic effects, and control of immune cells via cellcell interaction. We previously showed that conditioned medium of ADSCs promoted hepatocyte proliferation and improved the liver function in a mouse model of acute liver failure. Furthermore, as found by many other groups, the administration of ADSCs improved liver tissue fibrosis in a mouse model of liver cirrhosis. A comprehensive protein expression analysis by liquid chromatography with tandem mass spectrometry showed that the various cytokines and chemokines produced by ADSCs promote the healing of liver disease. In this review, we examine the ability of expressed protein components of ADSCs to promote healing in cell therapy for liver disease. Previous studies demonstrated that ADSCs are a treatment cell source for patients with chronic liver injury. This review describes the various cytokines and chemokines produced by ADSCs that promote the healing of liver disease.

Original languageEnglish
Pages (from-to)146-159
Number of pages14
JournalWorld Journal of Stem Cells
Volume10
Issue number11
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Mesenchymal Stromal Cells
Liver Diseases
Cytokines
Chemokines
Liver Cirrhosis
Liver
Acute Liver Failure
Subcutaneous Fat
Wounds and Injuries
Conditioned Culture Medium
Cell- and Tissue-Based Therapy
Tandem Mass Spectrometry
Liquid Chromatography
Hepatocytes
Intercellular Signaling Peptides and Proteins
Proteins
Therapeutics

Keywords

  • Adipose-derived mesenchymal stem cells
  • Cell transplantation therapy
  • Cytokine
  • Hepatocytes
  • Liquid chromatography with tandem mass spectrometry
  • Liver cirrhosis

ASJC Scopus subject areas

  • Histology
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cell Biology

Cite this

Nahar, S., Nakashima, Y., Miyagi-Shiohira, C., Kinjo, T., Toyoda, Z., Kobayashi, N., ... Fujita, J. (2018). Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease. World Journal of Stem Cells, 10(11), 146-159. https://doi.org/10.4252/wjsc.v10.i11.146

Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease. / Nahar, Saifun; Nakashima, Yoshiki; Miyagi-Shiohira, Chika; Kinjo, Takao; Toyoda, Zensei; Kobayashi, Naoya; Saitoh, Issei; Watanabe, Masami; Noguchi, Hirofumi; Fujita, Jiro.

In: World Journal of Stem Cells, Vol. 10, No. 11, 01.11.2018, p. 146-159.

Research output: Contribution to journalReview article

Nahar, S, Nakashima, Y, Miyagi-Shiohira, C, Kinjo, T, Toyoda, Z, Kobayashi, N, Saitoh, I, Watanabe, M, Noguchi, H & Fujita, J 2018, 'Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease', World Journal of Stem Cells, vol. 10, no. 11, pp. 146-159. https://doi.org/10.4252/wjsc.v10.i11.146
Nahar S, Nakashima Y, Miyagi-Shiohira C, Kinjo T, Toyoda Z, Kobayashi N et al. Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease. World Journal of Stem Cells. 2018 Nov 1;10(11):146-159. https://doi.org/10.4252/wjsc.v10.i11.146
Nahar, Saifun ; Nakashima, Yoshiki ; Miyagi-Shiohira, Chika ; Kinjo, Takao ; Toyoda, Zensei ; Kobayashi, Naoya ; Saitoh, Issei ; Watanabe, Masami ; Noguchi, Hirofumi ; Fujita, Jiro. / Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease. In: World Journal of Stem Cells. 2018 ; Vol. 10, No. 11. pp. 146-159.
@article{214daef211c64fbbabcdf3ceaefdb067,
title = "Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease",
abstract = "Adipose-derived mesenchymal stem cells (ADSCs) are a treatment cell source for patients with chronic liver injury. ADSCs are characterized by being harvested from the patient's own subcutaneous adipose tissue, a high cell yield (i.e., reduced immune rejection response), accumulation at a disease nidus, suppression of excessive immune response, production of various growth factors and cytokines, angiogenic effects, antiapoptotic effects, and control of immune cells via cellcell interaction. We previously showed that conditioned medium of ADSCs promoted hepatocyte proliferation and improved the liver function in a mouse model of acute liver failure. Furthermore, as found by many other groups, the administration of ADSCs improved liver tissue fibrosis in a mouse model of liver cirrhosis. A comprehensive protein expression analysis by liquid chromatography with tandem mass spectrometry showed that the various cytokines and chemokines produced by ADSCs promote the healing of liver disease. In this review, we examine the ability of expressed protein components of ADSCs to promote healing in cell therapy for liver disease. Previous studies demonstrated that ADSCs are a treatment cell source for patients with chronic liver injury. This review describes the various cytokines and chemokines produced by ADSCs that promote the healing of liver disease.",
keywords = "Adipose-derived mesenchymal stem cells, Cell transplantation therapy, Cytokine, Hepatocytes, Liquid chromatography with tandem mass spectrometry, Liver cirrhosis",
author = "Saifun Nahar and Yoshiki Nakashima and Chika Miyagi-Shiohira and Takao Kinjo and Zensei Toyoda and Naoya Kobayashi and Issei Saitoh and Masami Watanabe and Hirofumi Noguchi and Jiro Fujita",
year = "2018",
month = "11",
day = "1",
doi = "10.4252/wjsc.v10.i11.146",
language = "English",
volume = "10",
pages = "146--159",
journal = "World Journal of Stem Cells",
issn = "1948-0210",
publisher = "Baishideng Publishing Group",
number = "11",

}

TY - JOUR

T1 - Cytokines in adipose-derived mesenchymal stem cells promote the healing of liver disease

AU - Nahar, Saifun

AU - Nakashima, Yoshiki

AU - Miyagi-Shiohira, Chika

AU - Kinjo, Takao

AU - Toyoda, Zensei

AU - Kobayashi, Naoya

AU - Saitoh, Issei

AU - Watanabe, Masami

AU - Noguchi, Hirofumi

AU - Fujita, Jiro

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Adipose-derived mesenchymal stem cells (ADSCs) are a treatment cell source for patients with chronic liver injury. ADSCs are characterized by being harvested from the patient's own subcutaneous adipose tissue, a high cell yield (i.e., reduced immune rejection response), accumulation at a disease nidus, suppression of excessive immune response, production of various growth factors and cytokines, angiogenic effects, antiapoptotic effects, and control of immune cells via cellcell interaction. We previously showed that conditioned medium of ADSCs promoted hepatocyte proliferation and improved the liver function in a mouse model of acute liver failure. Furthermore, as found by many other groups, the administration of ADSCs improved liver tissue fibrosis in a mouse model of liver cirrhosis. A comprehensive protein expression analysis by liquid chromatography with tandem mass spectrometry showed that the various cytokines and chemokines produced by ADSCs promote the healing of liver disease. In this review, we examine the ability of expressed protein components of ADSCs to promote healing in cell therapy for liver disease. Previous studies demonstrated that ADSCs are a treatment cell source for patients with chronic liver injury. This review describes the various cytokines and chemokines produced by ADSCs that promote the healing of liver disease.

AB - Adipose-derived mesenchymal stem cells (ADSCs) are a treatment cell source for patients with chronic liver injury. ADSCs are characterized by being harvested from the patient's own subcutaneous adipose tissue, a high cell yield (i.e., reduced immune rejection response), accumulation at a disease nidus, suppression of excessive immune response, production of various growth factors and cytokines, angiogenic effects, antiapoptotic effects, and control of immune cells via cellcell interaction. We previously showed that conditioned medium of ADSCs promoted hepatocyte proliferation and improved the liver function in a mouse model of acute liver failure. Furthermore, as found by many other groups, the administration of ADSCs improved liver tissue fibrosis in a mouse model of liver cirrhosis. A comprehensive protein expression analysis by liquid chromatography with tandem mass spectrometry showed that the various cytokines and chemokines produced by ADSCs promote the healing of liver disease. In this review, we examine the ability of expressed protein components of ADSCs to promote healing in cell therapy for liver disease. Previous studies demonstrated that ADSCs are a treatment cell source for patients with chronic liver injury. This review describes the various cytokines and chemokines produced by ADSCs that promote the healing of liver disease.

KW - Adipose-derived mesenchymal stem cells

KW - Cell transplantation therapy

KW - Cytokine

KW - Hepatocytes

KW - Liquid chromatography with tandem mass spectrometry

KW - Liver cirrhosis

UR - http://www.scopus.com/inward/record.url?scp=85057228637&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057228637&partnerID=8YFLogxK

U2 - 10.4252/wjsc.v10.i11.146

DO - 10.4252/wjsc.v10.i11.146

M3 - Review article

AN - SCOPUS:85057228637

VL - 10

SP - 146

EP - 159

JO - World Journal of Stem Cells

JF - World Journal of Stem Cells

SN - 1948-0210

IS - 11

ER -